1. Дефицит витамина D. Клинические рекомендации РАЭ. М. 2021 [Defitsit vitamina D. Klinicheskie rekomendatsii RAE. Moscow. 2021 (in Russian)].
2. Pludowski P, Takacs I, Boyanov M, et al. Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. Nutrients. 2022;14(7). DOI:10.3390/nu14071483
3. Лесняк О.М., Никитинская О.А., Торопцова Н.В., и др. Профилактика, диагностика и лечение дефицита витамина D и кальция у взрослого населения России и пациентов с остеопорозом (по материалам подготовленных клинических рекомендаций). Научно-практическая ревматология. 2015;53(4):403-8 [Lesnyak OM, Nikitinskaya OA, Toroptsova NV, et al. The prevention, diagnosis, and treatment of vitamin D and calcium deficiencies in the adult population of russia and in patients with osteoporosis (according to the materials of prepared clinical recommendations). Rheumatology Science and Practice. 2015;53(4):403-8 (in Russian)]. DOI:10.14412/1995-4484-2015-403-408
4. Пигарова Е.А., Рожинская Л.Я., Белая Ж.Е., и др. Клинические рекомендации Российской ассоциации эндокринологов по диагностике, лечению и профилактике дефицита витамина D у взрослых. Проблемы Эндокринологии. 2016;62(4):60-84 [Pigarova EA, Rozhinskaya LYa, Belaya JE, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84 (in Russian)].
DOI:10.14341/probl201662460-84
5. Баранов И.И., Дорофейников В.В., Зазерская И.Е., и др. Междисциплинарное руководство по профилактике и лечению дефицита витамина D в прегравидарном периоде, во время беременности и после родов (код по Международной классификации болезней 10-го пересмотра – Е55). Под ред. Е.Н. Гриневой, И.Ю. Коган, Е.В. Уваровой. СПб.: Эко-Вектор, 2020 [Baranov II, Dorofeinikov VV, Zazerskaia IE, et al. Mezhdistsiplinarnoe rukovodstvo po profilaktike i lecheniiu defitsita vitamina D v pregravidarnom periode, vo vremia beremennosti i posle rodov (kod po Mezhdunarodnoi klassifikatsii boleznei 10-go peresmotra – E55). Pod red. EN Grinevoi, IIu Kogan, EV Uvarovoi. Saint Petersburg: Eko-Vektor, 2020 (in Russian)].
6. Профилактика, диагностика и лечение дефицита витамина D и кальция для взрослого населения и у пациентов с остеопорозом. Рекомендации РАОП. 2016 [Profilaktika, diagnostika i lechenie defitsita vitamina D i kal'tsiia dlia vzroslogo naseleniia i u patsientov s osteoporozom. Rekomendatsii RAOP. 2016 (in Russian)].
7. Нормальная беременность. Клинические рекомендации Минздрава России. 2023. Режим доступа: https://oagrt.ru/clinicalrec. Ссылка активна на 28.08.2024 [Normal'naia beremennost'. Klinicheskie rekomendatsii Minzdrava Rossii. 2023. Available at: https://oagrt.ru/clinicalrec. Accessed: 28.08.2024 (in Russian)].
8. Падения у лиц пожилого и старческого возраста. Клинические рекомендации Минздрава России. 2020 [Padeniia u lits pozhilogo i starcheskogo vozrasta. Klinicheskie rekomendatsii Minzdrava Rossii. 2020 (in Russian)].
9. Старческая астения. Клинические рекомендации Минздрава России. 2020 [Starcheskaia asteniia. Klinicheskie rekomendatsii Minzdrava Rossii. 2020 (in Russian)].
10. Хроническая боль у пациентов пожилого и старческого возраста. Клинические рекомендации Минздрава России. 2021 [Khronicheskaia bol' u patsientov pozhilogo i starcheskogo vozrasta. Klinicheskie rekomendatsii Minzdrava Rossii. 2021 (in Russian)].
11. Janoušek J, Pilařová V, Macáková K, et al. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit Rev Clin Lab Sci. 2022;59(8):517-54. DOI:10.1080/10408363.2022.2070595
12. Пигарова Е.А., Петрушкина А.А. Неклассические эффекты витамина D. Остеопороз и остеопатии. 2017;20(3):90-101 [Pigarova EA, Petrushkina AA. Non-classical effects of vitamin D. Osteoporosis and Bone Diseases. 2017;20(3):90-101 (in Russian)]. DOI:10.14341/osteo2017390-101
13. Ginde AA, Blatchford P, Breese K, et al. High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. J Am Geriatr Soc. 2017;65(3):496-503. DOI:10.1111/jgs.14679
14. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. DOI:10.1136/bmj.i6583
15. Sha S, Chen LJ, Brenner H, Schöttker B. Associations of 25-hydroxyvitamin D status and vitamin D supplementation use with mortality due to 18 frequent cancer types in the UK Biobank cohort. Eur J Cancer. 2023;191:113241. DOI:10.1016/j.ejca.2023.113241
16. Beltrán-García J, Osca-Verdegal R, Pallardó FV, et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants (Basel). 2020;9(10). DOI:10.3390/antiox9100936
17. Goddek S. Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate. Int J Infect Dis. 2020;99:286-90. DOI:10.1016/j.ijid.2020.07.080
18. Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis. JAMA Cardiol. 2019;4(8):765-76. DOI:10.1001/jamacardio.2019.1870
19. Zhang Y, Fang F, Tang J, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673. DOI:10.1136/bmj.l4673
20. Gallagher JC. Vitamin D and aging. Endocrinol Metab Clin North Am. 2013;42(2):319-2. DOI:10.1016/j.ecl.2013.02.004
21. Verlaan S, Maier AB, Bauer JM, et al. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults – the PROVIDE study. Clin Nutr. 2018;37(2):551-5. DOI:10.1016/j.clnu.2017.01.005
22. Jia J, Hu J, Huo X, et al. Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2019;90(12):1347-32. DOI:10.1136/jnnp-2018-320199
23. Harse JD, Zhu K, Bucks RS, et al. Investigating Potential Dose-Response Relationships between Vitamin D Status and Cognitive Performance: А Cross-Sectional Analysis in Middle- to Older-Aged Adults in the Busselton Healthy Ageing Study. Int J Environ Res Public Heals. 2021;19(1):450. DOI:10.3390/ijerph19010450
24. Shah VP, Nayfeh T, Alsawaf Y, et al. A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D. J Clin Endocrinol Metab. 2024;109(8):1961-94. DOI:10.1210/clinem/dgae312
25. Рунова Г.Е., Голоунина О.О., Глинкина И.В., Фадеев В.В. Первичный гиперпаратиреоз и дефицит витамина D. Терапевтический архив. 2021;93(10):1221-6 [Runova GE, Golounina OO, Glinkina I.V, Fadeev VV. Primary hyperparathyroidism and vitamin D deficiency. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(10):1221-6 (in Russian)]. DOI:10.26442/00403660.2021.10.201081
26. Алексеева Н.С. Лечение метаболического синдрома у молодых пациентов с дефицитом витамина D. Терапевтический архив. 2020;92(10):34-9 [Alekseeva NS. Treatment of metabolic syndrome in young patients with vitamin D deficiency. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(10):34-9 (in Russian)]. DOI:10.26442/00403660.2020.10.000370
27. Духанин А.С. Препараты витамина D: от действующего начала к терапевтическим эффектам. Лечащий Врач. 2022;9(25):66-71 [Dukhanin AS. Vitamin D drug formulation: from active substance to therapeutic effects. Lechaschi Vrach. 2022;9(25):66-71 (in Russian)]. DOI:10.51793/OS.2022.25.9.001
28. Суплотова Л.А., Авдеева В.А., Пигарова Е.А., и др. Первое российское многоцентровое неинтервенционное регистровое исследование по изучению частоты дефицита и недостаточности витамина D в Российской Федерации у взрослых. Терапевтический архив. 2021;93(10):1209-16 [Suplotova LA, Avdeeva VA, Pigarova EA, et al. The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(10):1209-16 (in Russian)]. DOI:10.26442/00403660.2021.10.201071
29. Захарова И.Н., Мальцев С.В., Боровик Т.Э., и др. Результаты многоцентрового исследования «РОДНИЧОК» по изучению недостаточности витамина D у детей раннего возраста в России. Педиатрия им. Г.Н. Сперанского. 2015;94(1):62-7 [Zaharova IN, Maltsev SV, Borovik TE, et al. Results of a multicenter research “Rodnichok” for the study of vitamin D insufficiency in infants in Russia. Pediatria n.a. GN Speransky. 2015;94(1):62-7 (in Russian)].
30. Saraf R, Morton SM, Camargo CAJr, Grant CC. Global summary of maternal and newborn vitamin D status – a systematic review. Matern Child Nutr. 2016;12(4):647-8. DOI:10.1111/mcn.12210
31. Платонова Н.М., Рыбакова А.А., Никанкина Л.В., и др. Витамин D и беременность: современное состояние проблемы в центральных регионах РФ. Проблемы Эндокринологии. 2020;66(6):81-7 [Platonova NM, Rybakova AA, Nikankina LV, et al. Vitamin D and pregnancy: current state of the problem in the central regions of the Russian Federation. Problems of Endocrinology. 2020;66(6):81-7 (in Russian)]. DOI:10.14341/probl12693
32. Karras S, Paschou SA, Kandaraki E, et al. Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review. Eur J Clin Nutr. 2016;70(9):979-86. DOI:10.1038/ejcn.2016.12
33. Purdue-Smithe AC, Whitcomb BW, Szegda KL, et al. Vitamin D and calcium intake and risk of early menopause. Am J Clin Nutr. 2017;105(6):1493-501. DOI:10.3945/ajcn.116.145607
34. Alinia T, Sabour S, Hashemipour M, et al. Relationship between vitamin D levels and age of menopause and reproductive lifespan: Analysis based on the National health and nutrition examination survey (NHANES) 2001-2018. Eur J Obstet Gynecol Reprod Biol. 2023;289:183-8. DOI:10.1016/j.ejogrb.2023.09.003
35. Hirani V, Cumming RG, Naganathan V, et al. Longitudinal Associations Between Vitamin D Metabolites and Sarcopenia in Older Australian men: The Concord Health and Aging in Men Project. J Gerontol A Biol Sci Med Sci. 2017;73(1):131-3. DOI:10.1093/gerona/glx086
36. Thanapluetiwong S, Chewcharat A, Takkavatakarn K, et al. Vitamin D supplement on prevention of fall and fracture: A Meta-analysis of Randomized Controlled Trials. Medicine (Baltimore). 2020;99(34):e21506. DOI:10.1097/MD.0000000000021506
37. Rosendahl-Riise H, Spielau U, Ranhoff AH, et al. Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis. J Hum Nutr Diet. 2017;30(1):3-15. DOI:10.1111/jhn.12394
38. De Spiegeleer A, Beckwée D, Bautmans I, et al. Pharmacological Interventions to Improve Muscle Mass, Muscle Strength and Physical Performance in Older People: An Umbrella Review of Systematic Reviews and Meta-analyses. Drugs Aging. 2018;35(8):719-34. DOI:10.1007/s40266-018-0566-y
39. Авдеева В.А., Сячина С.Н., Суплотова Л.А. Вторичный гиперпаратиреоз при хронической болезни почек у пациентов с сахарным диабетом: роль дефицита витамина D. Остеопороз и остеопатии. 2024;27(1):35-41 [Avdeeva VA, Syachina SN, Suplotova LA. Secondary hyperparathyroidism in chronic kidney disease in patients with diabetes mellitus: the role of vitamin D deficiency. Osteoporosis and Bone Diseases. 2024;27(1):35-41 (in Russian)]. DOI:10.14341/osteo13152
40. Пигарова Е.А., Дзеранова Л.К. Высокая распространенность низких уровней витамина D при эндокринных заболеваниях. Ожирение и метаболизм. 2021;18(4):398-405 [Pigarova EA, Dzeranova LK. High prevalence of low vitamin D levels in endocrine disorders. Obesity and Metabolism. 2021;18(4):398-405 (in Russian)]. DOI:10.14341/omet12799
41. Дефицит витамина D у взрослых: диагностика, лечение и профилактика. Клинические рекомендации РАЭ. М.–Тверь: Триада, 2020 [Defitsit vitamina D u vzroslykh: diagnostika, lechenie i profilaktika. Klinicheskie rekomendatsii RAE. Moscow–Tver: Triada, 2020 (in Russian)].
42. Пигарова Е.А., Поваляева А.А., Дзеранова Л.К., Рожинская Л.Я. Роль витамина D при эндокринных заболеваниях. Лабораторная служба. 2021;10(2):34-46 [Pigarova EA, Povaliaeva AA, Dzeranova LK, Rozhinskaya LYa. The role of vitamin D in endocrine diseases. Laboratory Service. 2021;10(2):34-46 (in Russian)]. DOI:10.17116/labs20211002134
43. Салухов В.В., Ковалевская Е.А., Курбанова В.В. Костные и внекостные эффекты витамина D, а также возможности медикаментозной коррекции его дефицита. Медицинский Совет. 2018;(4):90-9 [Salukhov VV, Kovalevskaya EA, Kurbanova VV. Osteal and extraosteal effects of vitamin D and its opportunities of medication correction of its deficiency. Medical Council. 2018;(4):90-9 (in Russian)]. DOI:10.21518/2079-701X-2018-4-90-99
44. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242-50.
DOI:10.7326/0003-4819-149-4-200808190-00005
45. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update. J Intern Med. 2006;259(6):539-2. DOI:10.1111/j.1365-2796.2006.01655.x
46. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415-23. DOI:10.1210/jc.2006-1404
47. Bouillon R, Van Schoor NM, Gielen E, et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab. 2013;98(8):E1283-304. DOI:10.1210/jc.2013-1195
48. Маганева И.С., Пигарова Е.А., Шульпекова Н.В., и др. Оценка фосфорно-кальциевого обмена и метаболитов витамина D у пациентов с первичным гиперпаратиреозом на фоне болюсной терапии колекальциферолом. Проблемы Эндокринологии. 2021;67(6):68-79 [Maganeva IS, Pigarova EA, Shulpekova NV, et al. Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol. Problems of Endocrinology. 2021;67(6):68-79 (in Russian)]. DOI:10.14341/probl12851
49. Елфимова А.Р., Еремкина А.К., Реброва О.Ю., и др. Ассоциация предоперационной терапии колекальциферолом и гипокальциемии после паратиреоидэктомии у больных с первичным гиперпаратиреозом. Проблемы Эндокринологии. 2024;70(1):38-45 [Elfimova AR, Eremkina AK, Rebrova OYu, et al. Association between preoperative cholecalciferol therapy and hypocalcemia after parathyroidectomy in patients with primary hyperparathyroidism. Problems of Endocrinology. 2024;70(1):38-45 (in Russian)]. DOI:10.14341/probl13324
50. Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, et al. Is vitamin D related to pathogenesis and treatment of Hashimoto's thyroiditis? Hell J Nucl Med. 2015;18(3):222-7.
51. Kivity S, Agmon-Levin N, Zisappl M, et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011;8(3):243-7. DOI:10.1038/cmi.2010.73
52. Yasuda T, Okamoto Y, Hamada N, et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine. 2012;42(3):739-41. DOI:10.1007/s12020-012-9679-y
53. Zhang H, Liang L, Xie Z. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease. Endocr Pract. 2015;21(3):258-63. DOI:10.4158/EP14191.OR
54. Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261-70. DOI:10.1007/s11892-012-0358-4
55. Zhang Y, Tan H, Tang J, et al. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2020;43(7):1650-68. DOI:10.2337/dc19-1708
56. Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis. J Endocr Soc. 2018;2(7):687-709. DOI:10.1210/js.2017-00472
57. Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab. 2017;102(9):3097-110. DOI:10.1210/jc.2017-01024
58. Azmi S, Ferdousi M, Kalteniece A, et al. Diagnosing and managing diabetic somatic and autonomic neuropathy. Ther Adv Endocrinol Metab. 2019;10:2042018819826890. DOI:10.1177/2042018819826890
59. Zhang B, Zhao W, Tu J, et al. The relationship between serum 25-hydroxyvitamin D concentration and type 2 diabetic peripheral neuropathy: A systematic review and a meta-analysis. Medicine (Baltimore). 2019;98(48):e18118. DOI:10.1097/MD.0000000000018118
60. Wang Y, Yang S, Zhou Q, et al. Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2019;44(1):72-87. DOI:10.1159/000498838
61. Giustina A, Bouillon R, Dawson-Hughes B, et al. Vitamin D in the older population: a consensus statement. Endocrine. 2023;79(1):31-44. DOI:10.1007/s12020-022-03208-3
62. Haghighat N, Sohrabi Z, Bagheri R, et al. A Systematic Review and Meta-Analysis of Vitamin D Status of Patients with Severe Obesity in Various Regions Worldwide. Obes Facts. 2023;16(6):519-39. DOI:10.1159/000533828
63. Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):389-94. DOI:10.1097/MED.0000000000000371
64. Borges JLC, Miranda ISM, Sarquis MMS, et al. Obesity, Bariatric Surgery, and Vitamin D. J Clin Densitom. 2018;21(2):157-62. DOI:10.1016/j.jocd.2017.03.001
65. Peterson LA, Cheskin LJ, Schweitzer MA, et al. Treatment for Vitamin D Deficiency Prior to Bariatric Surgery: a Prospective Cohort Study. Obes Surg. 2016;26(5):1146-9. DOI:10.1007/s11695-016-2115-2
66. Pellegrini M, Rahimi F, Boschetti S, et al. Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery. J Endocrinol Invest.
2021;44(7):1413-43. DOI:10.1007/s40618-020-01439-7
67. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48-55; discussion 54-5. DOI:10.1016/j.gassur.2003.09.020
68. De Niet S, Coffiner M, Da Silva S, et al. A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D3 Supplementation. Nutrients. 2018;10(6). DOI:10.3390/nu10060659
69. Galyean S, Syn D, Subih HS, Boylan M. Improving vitamin D status in bariatric surgery subjects with monthly high-dose ergocalciferol. Int J Vitam Nutr Res. 2022;92(2):109-17. DOI:10.1024/0300-9831/a000728
70. Carlin AM, Rao DS, Yager KM, et al. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009;5(4):444-9. DOI:10.1016/j.soard.2008.08.004
71. Iruretagoyena M, Hirigoyen D, Naves R, Burgos PI. Immune Response Modulation by Vitamin D: Role in Systemic Lupus Erythematosus. Front Immunol. 2015;6:513. DOI:10.3389/fimmu.2015.00513
72. Charoenngam N. Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence. Int J Mol Sci. 2021;22(19). DOI:10.3390/ijms221910659
73. Shipton EA, Shipton EE. Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities. Pain Res Treat. 2015:904967. DOI:10.1155/2015/904967
74. Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019;23(2):1-44. DOI:10.3310/hta23020
75. Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health. 2021;6(1). DOI:10.1136/bmjgh-2020-003176
76. Jordan T, Siuka D, Rotovnik NK, Pfeifer M. COVID-19 and Vitamin D – a Systematic Review. Zdr Varst. 2022;61(2):124-32. DOI:10.2478/sjph-2022-0017
77. Pereira M, Dantas Damascena A, Galvão Azevedo LM, et al. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr.
2022;62(5):1308-36. DOI:10.1080/10408398.2020.1841090
78. Grant WB, Lahore H, McDonnell SL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12(4). DOI:10.3390/nu12040988
79. Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One. 2013;8(6):e65835. DOI:10.1371/journal.pone.0065835
80. Каронова Т.Л., Руденко Е.В., Радаева О.А., и др. Обеспеченность населения витамином D в период пандемии COVID-19: опыт России и Беларуси. Известия Национальной академии наук Беларуси. Серия медицинских наук. 2022;19(4):424-32 [Karonova TL, Rudenco EV, Radaeva OA, et al. Vitamin D status during the COVID-19 pandemic: the experience of Russia and Belarus. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2022;19(4):424-32 (in Russian)]. DOI:10.29235/1814-6023-2022-19-4-424-432
81. Каронова Т.Л., Андреева А.Т., Головатюк К.А., и др. Инфицированность SARS-CoV-2 в зависимости от уровня обеспеченности витамином D. Проблемы Эндокринологии. 2021;67(5):20-8 [Karonova TL, Andreeva AT, Golovatyuk KA, et al. SARS-CoV-2 morbidity depending on vitamin D status. Problems of Endocrinology. 2021;67(5):20-8 (in Russian)]. DOI:10.14341/probl12820
82. Karonova TL, Kudryavtsev IV, Golovatyuk KA, et al. Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19. Pharmaceuticals (Basel). 2022;15(3). DOI:10.3390/ph15030305
83. Karonova TL, Golovatyuk KA, Kudryavtsev IV, et al. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study. Nutrients. 2022;14(13). DOI:10.3390/nu14132602
84. Karonova TL, Mikhaylova AA, Golovatyuk KA, et al. Vitamin D Metabolism Parameters and Cytokine Profile in COVID-19 Patients with Bolus Cholecalciferol Supplementation. Diagnostics (Basel). 2024;14(13). DOI:10.3390/diagnostics14131408
85. Маганева И.С., Бондаренко А.С., Милютина А.П., и др. Динамика показателей минерального обмена у госпитализированных пациентов с COVID-19, влияние этиотропной и патогенетической терапии. Проблемы Эндокринологии. 2023;69(4):77-86 [Maganeva IS, Bondarenko AS, Miliutina AP, et al. Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy. Problems of Endocrinology. 2023;69(4):77-86 (in Russian)]. DOI: 10.14341/probl13304
86. Povaliaeva A, Bogdanov V, Pigarova E, et al. Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients. Pharmaceuticals (Basel). 2022;15(8). DOI:10.3390/ph15080906
87. De Smet D, De Smet K, Herroelen P, et al. Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality. Am J Clin Pathol. 2021;155(3):381-8. DOI:10.1093/ajcp/aqaa252
88. Dupuis ML, Pagano MT, Pierdominici M, Ortona E. The role of vitamin D in autoimmune diseases: could sex make the difference? Biol Sex Differ. 2021;12(1):12.
DOI:10.1186/s13293-021-00358-3
89. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-95. DOI:10.1097/gme.0b013e31824d8f40
90. Guan Y, Hao Y, Guan Y, et al. The Effect of Vitamin D Supplementation on Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020;7:596007. DOI:10.3389/fmed.2020.596007
91. Chevalley T, Brandi ML, Cashman KD, et al. Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res. 2022;34(11):2603-63. DOI:10.1007/s40520-022-02279-6
92. Mouli VH, Schudrowitz N, Carrera CX, et al. High-Dose Vitamin D Supplementation Can Correct Hypovitaminosis D Prior to Total Knee Arthroplasty. J Arthroplasty. 2022;37(2):274-7. DOI:10.1016/j.arth.2021.10.016
93. Girgis CM, Clifton-Bligh RJ, Hamrick MW, et al. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34(1):33-83. DOI:10.1210/er.2012-1012
94. Molina P, Carrero JJ, Bover J, et al. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia, Sarcopenia and Muscle. 2017;8(5):686-701. DOI:10.1002/jcsm.12218.
95. Мачехина Л.В., Дудинская Е.Н., Ткачева О.Н. Дефицит витамина D у пожилых лиц с синдромом старческой астении. Профилактическая медицина. 2019;22(5):118-24 [Machekhina LV, Dudinskaya EN, Tkacheva ON. Vitamin D deficiency in elderly people with senile asthenia. The Russian Journal of Preventive Medicine. 2019;22(5):118-24 (in Russian)]. DOI:10.17116/profmed201922051118
96. Старческая астения. Клинические рекомендации Минздрава России. 2024 [Starcheskaia asteniia. Klinicheskie rekomendatsii Minzdrava Rossii. 2024 (in Russian)].
97. Ткачева О.Н., Котовская Ю.В., Мильто А.С., и др. Падения у пациентов пожилого и старческого возраста. Клинические рекомендации. Российский журнал гериатрической медицины. 2021;(2):153-85 [Tkacheva ON, Kotovskaya YuV, Mil'to AS, et al. Falls in older and senile patients. Clinical giudelines. Russian Journal of Geriatric Medicine. 2021;(2):153-85 (in Russian)]. DOI:10.37586/2686-8636-2-2021-148-174
98. Ткачева О.Н., Наумов А.В., Котовская Ю.В., и др. Хроническая боль у пациентов пожилого и старческого возраста. Клинические рекомендации. Российский журнал гериатрической медицины. 2021;(3):275-320 [Tkacheva ON, Naumov AV, Kotovskaya YuV, et al. Chronic pain in older and senile patients. Clinical guidelines. Russian Journal of Geriatric Medicine. 2021;(3):275-320 (in Russian)]. DOI:10.37586/2686-8636-3-2021-275-312
99. Wanigatunga AA, Sternberg AL, Blackford AL, et al. The effects of vitamin D supplementation on types of falls. J Am Geriatr Soc. 2021;69(10):2851-84. DOI:10.1111/jgs.17290
100. Camargo CA, Sluyter J, Stewart AW, et al. Effect of Monthly High-Dose Vitamin D Supplementation on Acute Respiratory Infections in Older Adults: A Randomized Controlled Trial. Clin Infect Dis. 2020;71(2):311-1. DOI:10.1093/cid/ciz801
101. McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience. J Steroid Biochem Mol Biol. 2019;189:228-39. DOI:10.1016/j.jsbmb.2018.12.010
102. Carlberg C, Velleuer E. Vitamin D and the risk for cancer: A molecular analysis. Biochem Pharmacol. 2022;196:114735. DOI:10.1016/j.bcp.2021.114735
103. Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993-4021. DOI:10.3390/nu5103993
104. Feldman D, Krishnan AV, Swami S, et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342-57. DOI:10.1038/nrc3691
105. Manson JE, Cook NR, Lee IM, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019;380(1):33-44. DOI:10.1056/NEJMoa1809944
106. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33(3):456-92. DOI:10.1210/er.2012-1000
107. Maurya VK, Aggarwal M. Factors influencing the absorption of vitamin D in GIT: an overview. J Food Sci Technol. 2017;54(12):3753-75. DOI:10.1007/s13197-017-2840-0
108. Пигарова Е.А., Дзеранова Л.К., Яценко Д.А. Витамин D – вопросы всасывания и метаболизма в норме и при заболеваниях желудочно-кишечного тракта. Ожирение и метаболизм. 2022;19(1):123-33 [Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and Metabolism. 2022;19(1):123-33 (in Russian)]. DOI:10.14341/omet12835
109. Reboul E, Goncalves A, Comera C, et al. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res. 2011;55(5):691-702. DOI:10.1002/mnfr.201000553
110. Borel P, Caillaud D, Cano NJ. Vitamin D bioavailability: state of the art. Crit Rev Food Sci Nutr. 2015;55(9):1193-205. DOI:10.1080/10408398.2012.688897
111. Поваляева А.А., Пигарова Е.А., Романова А.А., и др. Витамин D-связывающий белок как многофункциональный компонент сыворотки крови. Вестник Российской академии медицинских наук. 2021;76(1):103-10 [Povaliaeva AA, Pigarova EA, Romanova AA, et al. Vitamin D-Binding Protein: Multifunctional Component of Blood Serum. Annals of the Russian Academy of Medical Sciences. 2021;76(1):103-10 (in Russian)]. DOI:10.15690/vramn1396
112. Коцур Ю.М., Флисюк Е.В. Современные полимеры в технологии таблеток с пролонгированным высвобождением. Формулы Фармации. 2020;2(1):36-43 [Kotsur JM, Flisyuk EV. Modern polymers in prolonged release tablet technology. Pharmacy Formulas. 2020;2(1):36-43 (in Russian)]. DOI: 10.17816/phf21267
113. Sahota O, Mundey MK, San P, et al. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004;35(1):312-9. DOI:10.1016/j.bone.2004.02.003
114. Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305-12. DOI:10.1359/jbmr.090728
115. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. DOI:10.1210/jc.2011-0385
116. Giustina A, Bouillon R, Binkley N, et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 2020;4(12):e10417. DOI:10.1002/jbm4.10417
117. Bouillon R. Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol. 2017;13(8):466-79. DOI:10.1038/nrendo.2017.31
118. Fraile Navarro D, López García-Franco A, Niño de Guzmán E, et al. Vitamin D recommendations in clinical guidelines: A systematic review, quality evaluation and analysis of potential predictors. Int J Clin Pract. 2021;75(11):e14805. DOI:10.1111/ijcp.14805
119. Malihi Z, Lawes CMM, Wu Z, et al. Monthly high-dose vitamin D3 supplementation and self-reported adverse events in a 4-year randomized controlled trial. Clin Nutr. 2019;38(4):1581-57. DOI:10.1016/j.clnu.2018.07.034
120. Karampela I, Sakelliou A, Vallianou N, et al. Vitamin D and Obesity: Current Evidence and Controversies. Curr Obes Rep. 2021;10(2):162-80. DOI:10.1007/s13679-021-00433-1

________________________________________________

1. Defitsit vitamina D. Klinicheskie rekomendatsii RAE. Moscow. 2021 (in Russian).
2. Pludowski P, Takacs I, Boyanov M, et al. Clinical Practice in the Prevention, Diagnosis and Treatment of Vitamin D Deficiency: A Central and Eastern European Expert Consensus Statement. Nutrients. 2022;14(7). DOI:10.3390/nu14071483
3. Lesnyak OM, Nikitinskaya OA, Toroptsova NV, et al. The prevention, diagnosis, and treatment of vitamin D and calcium deficiencies in the adult population of russia and in patients with osteoporosis (according to the materials of prepared clinical recommendations). Rheumatology Science and Practice. 2015;53(4):403-8 (in Russian).
DOI:10.14412/1995-4484-2015-403-408
4. Pigarova EA, Rozhinskaya LYa, Belaya JE, et al. Russian Association of Endocrinologists recommendations for diagnosis, treatment and prevention of vitamin D deficiency in adults. Problems of Endocrinology. 2016;62(4):60-84 (in Russian). DOI:10.14341/probl201662460-84
5. Baranov II, Dorofeinikov VV, Zazerskaia IE, et al. Mezhdistsiplinarnoe rukovodstvo po profilaktike i lecheniiu defitsita vitamina D v pregravidarnom periode, vo vremia beremennosti i posle rodov (kod po Mezhdunarodnoi klassifikatsii boleznei 10-go peresmotra – E55). Pod red. EN Grinevoi, IIu Kogan, EV Uvarovoi. Saint Petersburg: Eko-Vektor, 2020 (in Russian).
6. Profilaktika, diagnostika i lechenie defitsita vitamina D i kal'tsiia dlia vzroslogo naseleniia i u patsientov s osteoporozom. Rekomendatsii RAOP. 2016 (in Russian).
7. Normal'naia beremennost'. Klinicheskie rekomendatsii Minzdrava Rossii. 2023. Available at: https://oagrt.ru/clinicalrec. Accessed: 28.08.2024 (in Russian).
8. Padeniia u lits pozhilogo i starcheskogo vozrasta. Klinicheskie rekomendatsii Minzdrava Rossii. 2020 (in Russian).
9. Starcheskaia asteniia. Klinicheskie rekomendatsii Minzdrava Rossii. 2020 (in Russian).
10. Khronicheskaia bol' u patsientov pozhilogo i starcheskogo vozrasta. Klinicheskie rekomendatsii Minzdrava Rossii. 2021 (in Russian).
11. Janoušek J, Pilařová V, Macáková K, et al. Vitamin D: sources, physiological role, biokinetics, deficiency, therapeutic use, toxicity, and overview of analytical methods for detection of vitamin D and its metabolites. Crit Rev Clin Lab Sci. 2022;59(8):517-54. DOI:10.1080/10408363.2022.2070595
12. Pigarova EA, Petrushkina AA. Non-classical effects of vitamin D. Osteoporosis and Bone Diseases. 2017;20(3):90-101 (in Russian). DOI:10.14341/osteo2017390-101
13. Ginde AA, Blatchford P, Breese K, et al. High-Dose Monthly Vitamin D for Prevention of Acute Respiratory Infection in Older Long-Term Care Residents: A Randomized Clinical Trial. J Am Geriatr Soc. 2017;65(3):496-503. DOI:10.1111/jgs.14679
14. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. DOI:10.1136/bmj.i6583
15. Sha S, Chen LJ, Brenner H, Schöttker B. Associations of 25-hydroxyvitamin D status and vitamin D supplementation use with mortality due to 18 frequent cancer types in the UK Biobank cohort. Eur J Cancer. 2023;191:113241. DOI:10.1016/j.ejca.2023.113241
16. Beltrán-García J, Osca-Verdegal R, Pallardó FV, et al. Oxidative Stress and Inflammation in COVID-19-Associated Sepsis: The Potential Role of Anti-Oxidant Therapy in Avoiding Disease Progression. Antioxidants (Basel). 2020;9(10). DOI:10.3390/antiox9100936
17. Goddek S. Vitamin D3 and K2 and their potential contribution to reducing the COVID-19 mortality rate. Int J Infect Dis. 2020;99:286-90. DOI:10.1016/j.ijid.2020.07.080
18. Barbarawi M, Kheiri B, Zayed Y, et al. Vitamin D Supplementation and Cardiovascular Disease Risks in More Than 83 000 Individuals in 21 Randomized Clinical Trials: A Meta-analysis. JAMA Cardiol. 2019;4(8):765-76. DOI:10.1001/jamacardio.2019.1870
19. Zhang Y, Fang F, Tang J, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673. DOI:10.1136/bmj.l4673
20. Gallagher JC. Vitamin D and aging. Endocrinol Metab Clin North Am. 2013;42(2):319-2. DOI:10.1016/j.ecl.2013.02.004
21. Verlaan S, Maier AB, Bauer JM, et al. Sufficient levels of 25-hydroxyvitamin D and protein intake required to increase muscle mass in sarcopenic older adults – the PROVIDE study. Clin Nutr. 2018;37(2):551-5. DOI:10.1016/j.clnu.2017.01.005
22. Jia J, Hu J, Huo X, et al. Effects of vitamin D supplementation on cognitive function and blood Aβ-related biomarkers in older adults with Alzheimer's disease: a randomised, double-blind, placebo-controlled trial. J Neurol Neurosurg Psychiatry. 2019;90(12):1347-32. DOI:10.1136/jnnp-2018-320199
23. Harse JD, Zhu K, Bucks RS, et al. Investigating Potential Dose-Response Relationships between Vitamin D Status and Cognitive Performance: А Cross-Sectional Analysis in Middle- to Older-Aged Adults in the Busselton Healthy Ageing Study. Int J Environ Res Public Heals. 2021;19(1):450. DOI:10.3390/ijerph19010450
24. Shah VP, Nayfeh T, Alsawaf Y, et al. A Systematic Review Supporting the Endocrine Society Clinical Practice Guidelines on Vitamin D. J Clin Endocrinol Metab. 2024;109(8):1961-94. DOI:10.1210/clinem/dgae312
25. Runova GE, Golounina OO, Glinkina I.V, Fadeev VV. Primary hyperparathyroidism and vitamin D deficiency. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(10):1221-6 (in Russian). DOI:10.26442/00403660.2021.10.201081
26. Alekseeva NS. Treatment of metabolic syndrome in young patients with vitamin D deficiency. Terapevticheskii Arkhiv (Ter. Arkh.). 2020;92(10):34-9 (in Russian). DOI:10.26442/00403660.2020.10.000370
27. Dukhanin AS. Vitamin D drug formulation: from active substance to therapeutic effects. Lechaschi Vrach. 2022;9(25):66-71 (in Russian). DOI:10.51793/OS.2022.25.9.001
28. Suplotova LA, Avdeeva VA, Pigarova EA, et al. The first Russian multicenter non-interventional registry study to study the incidence of vitamin D deficiency and insufficiency in Russian Federation. Terapevticheskii Arkhiv (Ter. Arkh.). 2021;93(10):1209-16 (in Russian). DOI:10.26442/00403660.2021.10.201071
29. Zaharova IN, Maltsev SV, Borovik TE, et al. Results of a multicenter research “Rodnichok” for the study of vitamin D insufficiency in infants in Russia. Pediatria n.a. GN Speransky. 2015;94(1):62-7 (in Russian).
30. Saraf R, Morton SM, Camargo CAJr, Grant CC. Global summary of maternal and newborn vitamin D status – a systematic review. Matern Child Nutr. 2016;12(4):647-8. DOI:10.1111/mcn.12210
31. Platonova NM, Rybakova AA, Nikankina LV, et al. Vitamin D and pregnancy: current state of the problem in the central regions of the Russian Federation. Problems of Endocrinology. 2020;66(6):81-7 (in Russian). DOI:10.14341/probl12693
32. Karras S, Paschou SA, Kandaraki E, et al. Hypovitaminosis D in pregnancy in the Mediterranean region: a systematic review. Eur J Clin Nutr. 2016;70(9):979-86. DOI:10.1038/ejcn.2016.12
33. Purdue-Smithe AC, Whitcomb BW, Szegda KL, et al. Vitamin D and calcium intake and risk of early menopause. Am J Clin Nutr. 2017;105(6):1493-501. DOI:10.3945/ajcn.116.145607
34. Alinia T, Sabour S, Hashemipour M, et al. Relationship between vitamin D levels and age of menopause and reproductive lifespan: Analysis based on the National health and nutrition examination survey (NHANES) 2001-2018. Eur J Obstet Gynecol Reprod Biol. 2023;289:183-8. DOI:10.1016/j.ejogrb.2023.09.003
35. Hirani V, Cumming RG, Naganathan V, et al. Longitudinal Associations Between Vitamin D Metabolites and Sarcopenia in Older Australian men: The Concord Health and Aging in Men Project. J Gerontol A Biol Sci Med Sci. 2017;73(1):131-3. DOI:10.1093/gerona/glx086
36. Thanapluetiwong S, Chewcharat A, Takkavatakarn K, et al. Vitamin D supplement on prevention of fall and fracture: A Meta-analysis of Randomized Controlled Trials. Medicine (Baltimore). 2020;99(34):e21506. DOI:10.1097/MD.0000000000021506
37. Rosendahl-Riise H, Spielau U, Ranhoff AH, et al. Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis. J Hum Nutr Diet. 2017;30(1):3-15. DOI:10.1111/jhn.12394
38. De Spiegeleer A, Beckwée D, Bautmans I, et al. Pharmacological Interventions to Improve Muscle Mass, Muscle Strength and Physical Performance in Older People: An Umbrella Review of Systematic Reviews and Meta-analyses. Drugs Aging. 2018;35(8):719-34. DOI:10.1007/s40266-018-0566-y
39. Avdeeva VA, Syachina SN, Suplotova LA. Secondary hyperparathyroidism in chronic kidney disease in patients with diabetes mellitus: the role of vitamin D deficiency. Osteoporosis and Bone Diseases. 2024;27(1):35-41 (in Russian). DOI:10.14341/osteo13152
40. Pigarova EA, Dzeranova LK. High prevalence of low vitamin D levels in endocrine disorders. Obesity and Metabolism. 2021;18(4):398-405 (in Russian). DOI:10.14341/omet12799
41. Defitsit vitamina D u vzroslykh: diagnostika, lechenie i profilaktika. Klinicheskie rekomendatsii RAE. Moscow–Tver: Triada, 2020 (in Russian).
42. Pigarova EA, Povaliaeva AA, Dzeranova LK, Rozhinskaya LYa. The role of vitamin D in endocrine diseases. Laboratory Service. 2021;10(2):34-46 (in Russian). DOI:10.17116/labs20211002134
43. Salukhov VV, Kovalevskaya EA, Kurbanova VV. Osteal and extraosteal effects of vitamin D and its opportunities of medication correction of its deficiency. Medical Council.
2018;(4):90-9 (in Russian). DOI:10.21518/2079-701X-2018-4-90-99
44. Cauley JA, Lacroix AZ, Wu L, et al. Serum 25-hydroxyvitamin D concentrations and risk for hip fractures. Ann Intern Med. 2008;149(4):242-50.
DOI:10.7326/0003-4819-149-4-200808190-00005
45. Boonen S, Vanderschueren D, Haentjens P, Lips P. Calcium and vitamin D in the prevention and treatment of osteoporosis – a clinical update. J Intern Med. 2006;259(6):539-2. DOI:10.1111/j.1365-2796.2006.01655.x
46. Boonen S, Lips P, Bouillon R, et al. Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials. J Clin Endocrinol Metab. 2007;92(4):1415-23. DOI:10.1210/jc.2006-1404
47. Bouillon R, Van Schoor NM, Gielen E, et al. Optimal vitamin D status: a critical analysis on the basis of evidence-based medicine. J Clin Endocrinol Metab. 2013;98(8):E1283-304. DOI:10.1210/jc.2013-1195
48. Maganeva IS, Pigarova EA, Shulpekova NV, et al. Vitamin D metabolite and calcium phosphorus metabolism in in patients with primary hyperparathyroidism on the background of bolus therapy with colecalciferol. Problems of Endocrinology. 2021;67(6):68-79 (in Russian). DOI:10.14341/probl12851
49. Elfimova AR, Eremkina AK, Rebrova OYu, et al. Association between preoperative cholecalciferol therapy and hypocalcemia after parathyroidectomy in patients with primary hyperparathyroidism. Problems of Endocrinology. 2024;70(1):38-45 (in Russian). DOI:10.14341/probl13324
50. Mazokopakis EE, Papadomanolaki MG, Tsekouras KC, et al. Is vitamin D related to pathogenesis and treatment of Hashimoto's thyroiditis? Hell J Nucl Med. 2015;18(3):222-7.
51. Kivity S, Agmon-Levin N, Zisappl M, et al. Vitamin D and autoimmune thyroid diseases. Cell Mol Immunol. 2011;8(3):243-7. DOI:10.1038/cmi.2010.73
52. Yasuda T, Okamoto Y, Hamada N, et al. Serum vitamin D levels are decreased and associated with thyroid volume in female patients with newly onset Graves' disease. Endocrine. 2012;42(3):739-41. DOI:10.1007/s12020-012-9679-y
53. Zhang H, Liang L, Xie Z. Low Vitamin D Status is Associated with Increased Thyrotropin-Receptor Antibody Titer in Graves Disease. Endocr Pract. 2015;21(3):258-63. DOI:10.4158/EP14191.OR
54. Pilz S, Kienreich K, Rutters F, et al. Role of vitamin D in the development of insulin resistance and type 2 diabetes. Curr Diab Rep. 2013;13(2):261-70. DOI:10.1007/s11892-012-0358-4
55. Zhang Y, Tan H, Tang J, et al. Effects of Vitamin D Supplementation on Prevention of Type 2 Diabetes in Patients With Prediabetes: A Systematic Review and Meta-analysis. Diabetes Care. 2020;43(7):1650-68. DOI:10.2337/dc19-1708
56. Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. Vitamin D Supplementation, Glycemic Control, and Insulin Resistance in Prediabetics: A Meta-Analysis. J Endocr Soc. 2018;2(7):687-709. DOI:10.1210/js.2017-00472
57. Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM. The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis. J Clin Endocrinol Metab. 2017;102(9):3097-110. DOI:10.1210/jc.2017-01024
58. Azmi S, Ferdousi M, Kalteniece A, et al. Diagnosing and managing diabetic somatic and autonomic neuropathy. Ther Adv Endocrinol Metab. 2019;10:2042018819826890. DOI:10.1177/2042018819826890
59. Zhang B, Zhao W, Tu J, et al. The relationship between serum 25-hydroxyvitamin D concentration and type 2 diabetic peripheral neuropathy: A systematic review and a meta-analysis. Medicine (Baltimore). 2019;98(48):e18118. DOI:10.1097/MD.0000000000018118
60. Wang Y, Yang S, Zhou Q, et al. Effects of Vitamin D Supplementation on Renal Function, Inflammation and Glycemic Control in Patients with Diabetic Nephropathy: a Systematic Review and Meta-Analysis. Kidney Blood Press Res. 2019;44(1):72-87. DOI:10.1159/000498838
61. Giustina A, Bouillon R, Dawson-Hughes B, et al. Vitamin D in the older population: a consensus statement. Endocrine. 2023;79(1):31-44. DOI:10.1007/s12020-022-03208-3
62. Haghighat N, Sohrabi Z, Bagheri R, et al. A Systematic Review and Meta-Analysis of Vitamin D Status of Patients with Severe Obesity in Various Regions Worldwide. Obes Facts. 2023;16(6):519-39. DOI:10.1159/000533828
63. Walsh JS, Bowles S, Evans AL. Vitamin D in obesity. Curr Opin Endocrinol Diabetes Obes. 2017;24(6):389-94. DOI:10.1097/MED.0000000000000371
64. Borges JLC, Miranda ISM, Sarquis MMS, et al. Obesity, Bariatric Surgery, and Vitamin D. J Clin Densitom. 2018;21(2):157-62. DOI:10.1016/j.jocd.2017.03.001
65. Peterson LA, Cheskin LJ, Schweitzer MA, et al. Treatment for Vitamin D Deficiency Prior to Bariatric Surgery: a Prospective Cohort Study. Obes Surg. 2016;26(5):1146-9. DOI:10.1007/s11695-016-2115-2
66. Pellegrini M, Rahimi F, Boschetti S, et al. Pre-operative micronutrient deficiencies in patients with severe obesity candidates for bariatric surgery. J Endocrinol Invest.
2021;44(7):1413-43. DOI:10.1007/s40618-020-01439-7
67. Slater GH, Ren CJ, Siegel N, et al. Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery. J Gastrointest Surg. 2004;8(1):48-55; discussion 54-5. DOI:10.1016/j.gassur.2003.09.020
68. De Niet S, Coffiner M, Da Silva S, et al. A Randomized Study to Compare a Monthly to a Daily Administration of Vitamin D3 Supplementation. Nutrients. 2018;10(6). DOI:10.3390/nu10060659
69. Galyean S, Syn D, Subih HS, Boylan M. Improving vitamin D status in bariatric surgery subjects with monthly high-dose ergocalciferol. Int J Vitam Nutr Res. 2022;92(2):109-17. DOI:10.1024/0300-9831/a000728
70. Carlin AM, Rao DS, Yager KM, et al. Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial. Surg Obes Relat Dis. 2009;5(4):444-9. DOI:10.1016/j.soard.2008.08.004
71. Iruretagoyena M, Hirigoyen D, Naves R, Burgos PI. Immune Response Modulation by Vitamin D: Role in Systemic Lupus Erythematosus. Front Immunol. 2015;6:513. DOI:10.3389/fimmu.2015.00513
72. Charoenngam N. Vitamin D and Rheumatic Diseases: A Review of Clinical Evidence. Int J Mol Sci. 2021;22(19). DOI:10.3390/ijms221910659
73. Shipton EA, Shipton EE. Vitamin D and Pain: Vitamin D and Its Role in the Aetiology and Maintenance of Chronic Pain States and Associated Comorbidities. Pain Res Treat. 2015:904967. DOI:10.1155/2015/904967
74. Martineau AR, Jolliffe DA, Greenberg L, et al. Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis. Health Technol Assess. 2019;23(2):1-44. DOI:10.3310/hta23020
75. Abioye AI, Bromage S, Fawzi W. Effect of micronutrient supplements on influenza and other respiratory tract infections among adults: a systematic review and meta-analysis. BMJ Glob Health. 2021;6(1). DOI:10.1136/bmjgh-2020-003176
76. Jordan T, Siuka D, Rotovnik NK, Pfeifer M. COVID-19 and Vitamin D – a Systematic Review. Zdr Varst. 2022;61(2):124-32. DOI:10.2478/sjph-2022-0017
77. Pereira M, Dantas Damascena A, Galvão Azevedo LM, et al. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr.
2022;62(5):1308-36. DOI:10.1080/10408398.2020.1841090
78. Grant WB, Lahore H, McDonnell SL, et al. Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients. 2020;12(4). DOI:10.3390/nu12040988
79. Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. PLoS One. 2013;8(6):e65835. DOI:10.1371/journal.pone.0065835
80. Karonova TL, Rudenco EV, Radaeva OA, et al. Vitamin D status during the COVID-19 pandemic: the experience of Russia and Belarus. Proceedings of the National Academy of Sciences of Belarus, Medical series. 2022;19(4):424-32 (in Russian). DOI:10.29235/1814-6023-2022-19-4-424-432
81. Karonova TL, Andreeva AT, Golovatyuk KA, et al. SARS-CoV-2 morbidity depending on vitamin D status. Problems of Endocrinology. 2021;67(5):20-8 (in Russian). DOI:10.14341/probl12820
82. Karonova TL, Kudryavtsev IV, Golovatyuk KA, et al. Vitamin D Status and Immune Response in Hospitalized Patients with Moderate and Severe COVID-19. Pharmaceuticals (Basel). 2022;15(3). DOI:10.3390/ph15030305
83. Karonova TL, Golovatyuk KA, Kudryavtsev IV, et al. Effect of Cholecalciferol Supplementation on the Clinical Features and Inflammatory Markers in Hospitalized COVID-19 Patients: A Randomized, Open-Label, Single-Center Study. Nutrients. 2022;14(13). DOI:10.3390/nu14132602
84. Karonova TL, Mikhaylova AA, Golovatyuk KA, et al. Vitamin D Metabolism Parameters and Cytokine Profile in COVID-19 Patients with Bolus Cholecalciferol Supplementation. Diagnostics (Basel). 2024;14(13). DOI:10.3390/diagnostics14131408
85. Maganeva IS, Bondarenko AS, Miliutina AP, et al. Dynamics the parameters of mineral metabolism in hospitalized patients with COVID-19, the impact of etiotropic and pathogenetic therapy. Problems of Endocrinology. 2023;69(4):77-86 (in Russian). DOI: 10.14341/probl13304
86. Povaliaeva A, Bogdanov V, Pigarova E, et al. Impaired Vitamin D Metabolism in Hospitalized COVID-19 Patients. Pharmaceuticals (Basel). 2022;15(8). DOI:10.3390/ph15080906
87. De Smet D, De Smet K, Herroelen P, et al. Serum 25(OH)D Level on Hospital Admission Associated With COVID-19 Stage and Mortality. Am J Clin Pathol. 2021;155(3):381-8. DOI:10.1093/ajcp/aqaa252
88. Dupuis ML, Pagano MT, Pierdominici M, Ortona E. The role of vitamin D in autoimmune diseases: could sex make the difference? Biol Sex Differ. 2021;12(1):12.
DOI:10.1186/s13293-021-00358-3
89. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging. Menopause. 2012;19(4):387-95. DOI:10.1097/gme.0b013e31824d8f40
90. Guan Y, Hao Y, Guan Y, et al. The Effect of Vitamin D Supplementation on Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 2020;7:596007. DOI:10.3389/fmed.2020.596007
91. Chevalley T, Brandi ML, Cashman KD, et al. Role of vitamin D supplementation in the management of musculoskeletal diseases: update from an European Society of Clinical and Economical Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) working group. Aging Clin Exp Res. 2022;34(11):2603-63. DOI:10.1007/s40520-022-02279-6
92. Mouli VH, Schudrowitz N, Carrera CX, et al. High-Dose Vitamin D Supplementation Can Correct Hypovitaminosis D Prior to Total Knee Arthroplasty. J Arthroplasty. 2022;37(2):274-7. DOI:10.1016/j.arth.2021.10.016
93. Girgis CM, Clifton-Bligh RJ, Hamrick MW, et al. The roles of vitamin D in skeletal muscle: form, function, and metabolism. Endocr Rev. 2013;34(1):33-83. DOI:10.1210/er.2012-1012
94. Molina P, Carrero JJ, Bover J, et al. Vitamin D, a modulator of musculoskeletal health in chronic kidney disease. J Cachexia, Sarcopenia and Muscle. 2017;8(5):686-701. DOI:10.1002/jcsm.12218.
95. Machekhina LV, Dudinskaya EN, Tkacheva ON. Vitamin D deficiency in elderly people with senile asthenia. The Russian Journal of Preventive Medicine. 2019;22(5):118-24 (in Russian). DOI:10.17116/profmed201922051118
96. Starcheskaia asteniia. Klinicheskie rekomendatsii Minzdrava Rossii. 2024 (in Russian).
97. Tkacheva ON, Kotovskaya YuV, Mil'to AS, et al. Falls in older and senile patients. Clinical giudelines. Russian Journal of Geriatric Medicine. 2021;(2):153-85 (in Russian). DOI:10.37586/2686-8636-2-2021-148-174
98. Tkacheva ON, Naumov AV, Kotovskaya YuV, et al. Chronic pain in older and senile patients. Clinical guidelines. Russian Journal of Geriatric Medicine. 2021;(3):275-320 (in Russian). DOI:10.37586/2686-8636-3-2021-275-312
99. Wanigatunga AA, Sternberg AL, Blackford AL, et al. The effects of vitamin D supplementation on types of falls. J Am Geriatr Soc. 2021;69(10):2851-84. DOI:10.1111/jgs.17290
100. Camargo CA, Sluyter J, Stewart AW, et al. Effect of Monthly High-Dose Vitamin D Supplementation on Acute Respiratory Infections in Older Adults: A Randomized Controlled Trial. Clin Infect Dis. 2020;71(2):311-1. DOI:10.1093/cid/ciz801
101. McCullough PJ, Lehrer DS, Amend J. Daily oral dosing of vitamin D3 using 5000 TO 50,000 international units a day in long-term hospitalized patients: Insights from a seven year experience. J Steroid Biochem Mol Biol. 2019;189:228-39. DOI:10.1016/j.jsbmb.2018.12.010
102. Carlberg C, Velleuer E. Vitamin D and the risk for cancer: A molecular analysis. Biochem Pharmacol. 2022;196:114735. DOI:10.1016/j.bcp.2021.114735
103. Moukayed M, Grant WB. Molecular link between vitamin D and cancer prevention. Nutrients. 2013;5(10):3993-4021. DOI:10.3390/nu5103993
104. Feldman D, Krishnan AV, Swami S, et al. The role of vitamin D in reducing cancer risk and progression. Nat Rev Cancer. 2014;14(5):342-57. DOI:10.1038/nrc3691
105. Manson JE, Cook NR, Lee IM, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. N Engl J Med. 2019;380(1):33-44. DOI:10.1056/NEJMoa1809944
106. Rosen CJ, Adams JS, Bikle DD, et al. The nonskeletal effects of vitamin D: an Endocrine Society scientific statement. Endocr Rev. 2012;33(3):456-92. DOI:10.1210/er.2012-1000
107. Maurya VK, Aggarwal M. Factors influencing the absorption of vitamin D in GIT: an overview. J Food Sci Technol. 2017;54(12):3753-75. DOI:10.1007/s13197-017-2840-0
108. Pigarova EA, Dzeranova LК, Yatsenko DA. Absorption and metabolism of vitamin D in health and in gastrointestinal tract diseases. Obesity and Metabolism. 2022;19(1):123-33 (in Russian). DOI:10.14341/omet12835
109. Reboul E, Goncalves A, Comera C, et al. Vitamin D intestinal absorption is not a simple passive diffusion: evidences for involvement of cholesterol transporters. Mol Nutr Food Res. 2011;55(5):691-702. DOI:10.1002/mnfr.201000553
110. Borel P, Caillaud D, Cano NJ. Vitamin D bioavailability: state of the art. Crit Rev Food Sci Nutr. 2015;55(9):1193-205. DOI:10.1080/10408398.2012.688897
111. Povaliaeva AA, Pigarova EA, Romanova AA, et al. Vitamin D-Binding Protein: Multifunctional Component of Blood Serum. Annals of the Russian Academy of Medical Sciences. 2021;76(1):103-10 (in Russian). DOI:10.15690/vramn1396
112. Kotsur JM, Flisyuk EV. Modern polymers in prolonged release tablet technology. Pharmacy Formulas. 2020;2(1):36-43 (in Russian). DOI: 10.17816/phf21267
113. Sahota O, Mundey MK, San P, et al. The relationship between vitamin D and parathyroid hormone: calcium homeostasis, bone turnover, and bone mineral density in postmenopausal women with established osteoporosis. Bone. 2004;35(1):312-9. DOI:10.1016/j.bone.2004.02.003
114. Priemel M, von Domarus C, Klatte TO, et al. Bone mineralization defects and vitamin D deficiency: histomorphometric analysis of iliac crest bone biopsies and circulating 25-hydroxyvitamin D in 675 patients. J Bone Miner Res. 2010;25(2):305-12. DOI:10.1359/jbmr.090728
115. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911-30. DOI:10.1210/jc.2011-0385
116. Giustina A, Bouillon R, Binkley N, et al. Controversies in Vitamin D: A Statement From the Third International Conference. JBMR Plus. 2020;4(12):e10417. DOI:10.1002/jbm4.10417
117. Bouillon R. Comparative analysis of nutritional guidelines for vitamin D. Nat Rev Endocrinol. 2017;13(8):466-79. DOI:10.1038/nrendo.2017.31
118. Fraile Navarro D, López García-Franco A, Niño de Guzmán E, et al. Vitamin D recommendations in clinical guidelines: A systematic review, quality evaluation and analysis of potential predictors. Int J Clin Pract. 2021;75(11):e14805. DOI:10.1111/ijcp.14805
119. Malihi Z, Lawes CMM, Wu Z, et al. Monthly high-dose vitamin D3 supplementation and self-reported adverse events in a 4-year randomized controlled trial. Clin Nutr. 2019;38(4):1581-57. DOI:10.1016/j.clnu.2018.07.034
120. Karampela I, Sakelliou A, Vallianou N, et al. Vitamin D and Obesity: Current Evidence and Controversies. Curr Obes Rep. 2021;10(2):162-80. DOI:10.1007/s13679-021-00433-1